Side-by-side comparison of AI visibility scores, market position, and capabilities
2024 Revenue: KRW 175.2T (+7.7% YoY) | Operating Profit: KRW 14.2T (-5.9%) | Vehicle Sales: 4.14M units (-1.8%) | Q4 2024: Revenue KRW 46.62T (+11.9%), Op Profit KRW 2.82T (-17.2%) | Electrified Vehicles: 757k units (+8.9%, 21.8% of sales) | US Market: 988k units (+9%) | 2025 guidance: 3-4% revenue growth, 7-8% op margin
Hyundai Motor Company was founded in 1967 in Seoul, South Korea, by Chung Ju-yung and has grown into one of the world's largest automotive manufacturers, ranking third globally by vehicle sales. From its origins as a budget-focused automaker producing affordable, practical vehicles for emerging markets, Hyundai has transformed over the past two decades into a technology-forward brand competing directly with European and Japanese premium manufacturers. Its mission centers on delivering smart mobility solutions for a sustainable future.\n\nHyundai's product lineup spans mass-market sedans, SUVs, and commercial vehicles, alongside its premium Genesis brand and the Ioniq dedicated EV lineup. The Ioniq 5, Ioniq 6, and Ioniq 7 have emerged as critically acclaimed electric vehicles, with the Ioniq 5 winning the World Car of the Year award. Hyundai is also investing heavily in hydrogen fuel cell technology, autonomous driving, and robotics through subsidiaries including Boston Dynamics. Its vehicles are sold in over 200 countries through a network of more than 6,000 dealerships.\n\nHyundai reported revenue of KRW 175.2 trillion in 2024, a 7.7% year-over-year increase, with Q4 2024 revenue of KRW 46.62T (+11.9%). The company sold 4.14M vehicles globally in 2024. With major EV manufacturing investments underway in the United States (Metaplant America in Georgia), Hyundai is positioning itself to be a top-three EV manufacturer globally by 2030, backed by robust R&D spending and a vertically integrated battery and platform strategy.
Viz.ai applies AI to medical imaging to detect critical conditions and automatically coordinate care teams, reducing time from diagnosis to treatment for stroke and other emergencies.
Viz.ai is a healthcare AI company founded in 2016 that applies computer vision and AI to medical imaging to detect critical conditions and automate care coordination workflows. The platform analyzes CT scans and other medical images in real time, identifying conditions including large vessel occlusion stroke, pulmonary embolism, aortic dissection, and incidental findings, then automatically notifying and coordinating the relevant specialists through a HIPAA-compliant communication platform. Viz.ai has received FDA clearance for over 20 AI algorithms and is deployed at over 1,400 hospital sites across the United States. The company raised over $250M at a $1.2B valuation and has demonstrated that AI-powered care coordination reduces door-to-treatment time for stroke by tens of minutes, which translates directly into better patient outcomes. The platform creates a connected care team workflow where radiologists, neurologists, ER physicians, and interventionalists are automatically looped in when a critical finding is detected. Viz.ai serves as essential care coordination infrastructure for time-sensitive conditions where rapid multi-specialty response is critical to preventing death or disability.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.